Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Avanos Medical (AVNS) Interest & Investment Income (2016 - 2025)

Avanos Medical's Interest & Investment Income history spans 12 years, with the latest figure at $700000.0 for Q3 2024.

  • For Q3 2024, Interest & Investment Income fell 22.22% year-over-year to $700000.0; the TTM value through Sep 2024 reached $5.3 million, up 103.85%, while the annual FY2023 figure was $2.9 million, 141.67% up from the prior year.
  • Interest & Investment Income for Q3 2024 was $700000.0 at Avanos Medical, down from $3.0 million in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $3.0 million in Q2 2024 and bottomed at $100000.0 in Q4 2020.
  • The 5-year median for Interest & Investment Income is $500000.0 (2023), against an average of $653333.3.
  • The largest annual shift saw Interest & Investment Income crashed 90.0% in 2020 before it skyrocketed 500.0% in 2024.
  • A 5-year view of Interest & Investment Income shows it stood at $100000.0 in 2020, then skyrocketed by 100.0% to $200000.0 in 2021, then soared by 250.0% to $700000.0 in 2022, then soared by 42.86% to $1.0 million in 2023, then decreased by 30.0% to $700000.0 in 2024.
  • Per Business Quant, the three most recent readings for AVNS's Interest & Investment Income are $700000.0 (Q3 2024), $3.0 million (Q2 2024), and $600000.0 (Q1 2024).